These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6888111)

  • 21. Current status of prophylactic surgery for hereditary breast and gynecologic cancers.
    Lynch HT; Casey MJ
    Curr Opin Obstet Gynecol; 2001 Feb; 13(1):25-30. PubMed ID: 11176229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [On the early detection of female genital and breast cancers in Bavarian women].
    Soost HJ
    Minerva Ginecol; 1971 Apr; 23(8):371-6. PubMed ID: 5568869
    [No Abstract]   [Full Text] [Related]  

  • 23. Acceptance for preventive genetic testing and prophylactic surgery in women with a family history of breast and gynaecological cancers.
    Ackermann S; Lux MP; Fasching PA; Strissl P; Renner SP; Poehls U; Bender HG; Beckmann MW
    Eur J Cancer Prev; 2006 Dec; 15(6):474-9. PubMed ID: 17106324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hormonal carcinogenesis in women: from mechanisms to prevention].
    Rochefort H
    C R Biol; 2008 Feb; 331(2):104-13. PubMed ID: 18241803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Epidemiology of gynecologic neoplasms in Saarland. Contribution to the effectiveness of neoplasm prevention in gynecology].
    Müller K; Sachs H; Grelich B
    Med Welt; 1975 Jun; 26(24):1193-8. PubMed ID: 1160591
    [No Abstract]   [Full Text] [Related]  

  • 26. [Recommendation for prophylactic surgery for decreasing the risk of gynaecological cancer in women with hereditary risk].
    Zikán M; Kalábová R
    Klin Onkol; 2009; 22 Suppl():S58-9. PubMed ID: 19764400
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevention practices and cancer screening among general practitioners in Picardy (France)].
    Ganry O; Boche T
    Bull Cancer; 2004 Oct; 91(10):785-91. PubMed ID: 15556879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Potential tumor preventive effects of hormone preparations].
    Kreienberg R; Rossmanith WG
    Gynakologe; 1993 Apr; 26(2):149-56. PubMed ID: 8508984
    [No Abstract]   [Full Text] [Related]  

  • 29. [Primary prevention trial of breast cancer by tamoxifen: the position of the French Society of Mammography and Breast Pathology].
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(6):727-8. PubMed ID: 7995922
    [No Abstract]   [Full Text] [Related]  

  • 30. Educating women about early detection of gynecologic cancers using a brochure.
    Mahon SM
    Oncol Nurs Forum; 1996 Apr; 23(3):529-31. PubMed ID: 8801514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A model of the prevention of malignant female genital neoplasms introduced into the gynecological health services in the Bialystok macroregion].
    Soszka S; Kazanowska W; Knapp P
    Probl Med Wieku Rozwoj; 1983; 12():220-6. PubMed ID: 6674975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance.
    Brown GJ; St John DJ; Macrae FA; Aittomäki K
    Gynecol Oncol; 2001 Mar; 80(3):346-9. PubMed ID: 11263929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Value of the detection of malignant gynecologic diseases in industrial medicine].
    Des Roseaux J; Andlauer P; Haour P; Conti C
    Arch Mal Prof; 1966; 27(1):67-9. PubMed ID: 5905779
    [No Abstract]   [Full Text] [Related]  

  • 34. Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.
    Lancaster JM; Powell CB; Kauff ND; Cass I; Chen LM; Lu KH; Mutch DG; Berchuck A; Karlan BY; Herzog TJ;
    Gynecol Oncol; 2007 Nov; 107(2):159-62. PubMed ID: 17950381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gynecologic cancers--the limits of preventive examination. An analysis of the current staging and percentage distributions based on 3,849 cancers from the 1 January 1983 to 25 November 1985 cumulative statistics of the study group of Swiss gynecologic clinics].
    Hochuli E; Benz J; Litschgi M; Marti WK
    Schweiz Rundsch Med Prax; 1986 Jun; 75(26):792-8. PubMed ID: 3489265
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum antibodies to the 27-kd heat shock protein in women with gynecologic cancers.
    Korneeva I; Bongiovanni AM; Girotra M; Caputo TA; Witkin SS
    Am J Obstet Gynecol; 2000 Jul; 183(1):18-21. PubMed ID: 10920302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Breast cancer: epidemiology, risk factors, screening].
    Gairard B; Mathelin C; Schaffer P; Brettes JP
    Rev Prat; 1998 Jan; 48(1):21-7. PubMed ID: 9781206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population-based cancer screening.
    Champion VL; Rawl SM; Menon U
    Oncol Nurs Forum; 2002 Jun; 29(5):853-61. PubMed ID: 12058160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost effectiveness in context.
    Schechter CB
    J Clin Oncol; 2007 Feb; 25(6):609-10. PubMed ID: 17308263
    [No Abstract]   [Full Text] [Related]  

  • 40. [Screening for malignant gynecologic tumors].
    Ebeling K
    Z Arztl Fortbild (Jena); 1993 Sep; 87(9):715-9. PubMed ID: 8237067
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.